Reversal of Apixaban Anticoagulation
Apixaban is a direct oral anticoagulant (DOAC) that selectively inhibits factor Xa, thereby preventing thrombin generation and clot formation. It is commonly prescribed for stroke prevention in atrial fibrillation, treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). While apixaban offers a predictable pharmacokinetic profile and reduced monitoring requirements, major bleeding or